Skip to main content

What the FDA labels say about taking them together

Paroxetine and tetrabenazine

Tetrabenazine's FDA label of November 29, 2019 names paroxetine in its drug interactions section; the paroxetine labels PlainMeds reads (4) do not name tetrabenazine. The tetrabenazine label: “Strong CYP2D6 inhibitors markedly increase exposure to these metabolites.”

Check it at the source: the paroxetine FDA label on DailyMed (effective February 12, 2026, Mylan Pharmaceuticals Inc.); the tetrabenazine FDA label on DailyMed (effective November 29, 2019, Oceanside Pharmaceuticals).

What does the paroxetine label say about tetrabenazine?

Paroxetine's label (effective February 12, 2026) and its 3 other brand-application labels do not name tetrabenazine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Paroxetine), Mylan Pharmaceuticals Inc., effective February 12, 2026 (SPL set 89dd7e24-85fc-4152-89ea-47ec2b48a1ed), via openFDA; the full label on DailyMed

What does the tetrabenazine label say about paroxetine?

Tetrabenazine label, drug interactions

Strong CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, quinidine) markedly increase exposure to these metabolites.

Tetrabenazine label, warnings and precautions

Do not exceed 50 mg/day and the maximum single dose should not exceed 25 mg if administered in conjunction with a strong CYP2D6 inhibitor (e.g., fluoxetine, paroxetine).

Source: FDA drug label (tetrabenazine), NDA021894 (Bausch), as published by Oceanside Pharmaceuticals, effective November 29, 2019 (SPL set 5867189c-17bd-4e70-a079-c4730f9950d1), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

45Paroxetine generic labelers
10Tetrabenazine generic labelers
ParoxetineTetrabenazine
Labeled forDepression, Anxiety, Menopause symptomsn/a
Boxed warningYesYes
Pharmacy cost (NADAC)$0.0611 per tablet 20 mg tablet$0.702 per tablet 12.5 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?